Jim Cramer Discusses These 10 Stocks & Says He’s In Waiting For AI GPU Spending Clarity

8. Danaher Corporation (NYSE:DHR)

Number of Hedge Fund Holders In Q3 2024: 98

Danaher Corporation (NYSE:DHR) is a life sciences firm that provides raw materials to biotechnology and other associated industries. 2024 was not a great month for biotech or other research-intensive stocks as high rates squeezed funding. As a result, Danaher Corporation (NYSE:DHR)’s shares closed the year flat after an 11% drop in October that stemmed from weak guidance. In his previous comments, Cramer has pinned some of the firm’s weakness on a slow Chinese economy. His latest remarks for Danaher Corporation (NYSE:DHR) came during his Morning Take from his Investing Club morning meeting:

“We’re just gonna skip for a second to a company I mentioned at the monthly meeting that I was extremely disappointed in. And that is Danaher. I don’t like to bury any losers, that’s the type of thing that people say is cherry-picking. While I said that I was deeply disappointed in the company, it was far worse than that. I’ll tell you why it’s far worse and then get over some of the good things. Because I’m not calling the company delusional. I am just saying they are ill-advised. Rene Blair, the CEO, starts his conference call, saying they believe ‘we’ve finished the year strong, with better than anticipated core revenue. That’s the end. Okay, that’s the end. They have no credibility whatsoever. I wanna point that out that I’m going from disappointed on the meeting, to frankly that I have no hope for these guys. And this is the opposite, say of Starbucks, where we knew at seventy seven, seventy eight that we should stick with it. And I don’t appreciate their glib nature and their lack of urgency and their complacency. Which is not Danaher. I don’t know who’s running that company right now but it’s not Danaher.”